Methods for inhibiting angiogenesis using EGFL8 antagonists
US9549971B2 · kind B2 · utility
0Cited by
0References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 14, 2009 |
| Grant date | Jan 24, 2017 |
| Priority date | — |
| Expiry date | Oct 17, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA01K2267/0375
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods of using EGFL8 antagonists to inhibit vascular development and to treat related disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.